Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #445
- Final score
- 52.30
- Years on list
- 6
↗ Climbed 293 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 293 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 105 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 48 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | ALNY | PRGO | IQV |
|---|---|---|---|
| Climate Change | 48.5 | 58.7 | 78.2 |
| Employee Relations | 63.5 | 40.8 | 47.8 |
| Environment | 61.1 | 55.8 | 36.7 |
| Stakeholders & Society | 48.7 | 50.9 | 63.1 |
| Human Rights | 31.7 | 74.6 | 23.2 |
| Governance | 42.1 | 37.2 | 55.4 |
| Performance Rating | 64.7 | 40.1 | 42.9 |